BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23352121)

  • 1. Campaign to counter a deteriorating consumer market: Philip Morris's Project Sunrise.
    Givel M
    Public Health; 2013 Feb; 127(2):134-42. PubMed ID: 23352121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Philip Morris's Project Sunrise: weakening tobacco control by working with it.
    McDaniel PA; Smith EA; Malone RE
    Tob Control; 2006 Jun; 15(3):215-23. PubMed ID: 16728753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Philip Morris's website and television commercials use new language to mislead the public into believing it has changed its stance on smoking and disease.
    Friedman LC
    Tob Control; 2007 Dec; 16(6):e9. PubMed ID: 18048599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Philip Morris's pursuit of US government regulation of tobacco.
    McDaniel PA; Malone RE
    Tob Control; 2005 Jun; 14(3):193-200. PubMed ID: 15923470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public versus internal conceptions of addiction: An analysis of internal Philip Morris documents.
    Elias J; Hendlin YH; Ling PM
    PLoS Med; 2018 May; 15(5):e1002562. PubMed ID: 29715300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco industry consumer research on socially acceptable cigarettes.
    Ling PM; Glantz SA
    Tob Control; 2005 Oct; 14(5):e3. PubMed ID: 16183968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
    Muggli ME; Hurt RD; Becker LB
    Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Making big tobacco give in: you lose, they win.
    Wander N; Malone RE
    Am J Public Health; 2006 Nov; 96(11):2048-54. PubMed ID: 17018823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the relationship between sales of legal cigarettes and deaths: A case-study in Brazil.
    Szklo AS; Iglesias RM; de Souza MC; Szklo M; Cavalcante TM; de Almeida LM
    Prev Med; 2017 Jan; 94():55-59. PubMed ID: 27856337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thinking the "unthinkable": why Philip Morris considered quitting.
    Smith EA; Malone RE
    Tob Control; 2003 Jun; 12(2):208-13. PubMed ID: 12773733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From adversary to target market: the ACT-UP boycott of Philip Morris.
    Offen N; Smith EA; Malone RE
    Tob Control; 2003 Jun; 12(2):203-7. PubMed ID: 12773732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke.
    Cook DM; Tong EK; Glantz SA; Bero LA
    Health Aff (Millwood); 2005; 24(4):994-1004. PubMed ID: 16136637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded 'Project Star' report.
    Gilmore AB; Rowell A; Gallus S; Lugo A; Joossens L; Sims M
    Tob Control; 2014 May; 23(e1):e51-61. PubMed ID: 24335339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Creative Solutions": selling cigarettes in a smoke-free world.
    Smith EA; Malone RE
    Tob Control; 2004 Mar; 13(1):57-63. PubMed ID: 14985598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altria means tobacco: Philip Morris's identity crisis.
    Smith EA; Malone RE
    Am J Public Health; 2003 Apr; 93(4):553-6. PubMed ID: 12660196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.
    Tong EK; Glantz SA
    Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "What Is Our Story?" Philip Morris's Changing Corporate Narrative.
    McDaniel PA; Malone RE
    Am J Public Health; 2015 Oct; 105(10):e68-75. PubMed ID: 26270280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has the tobacco industry evaded the FDA's ban on 'Light' cigarette descriptors?
    Connolly GN; Alpert HR
    Tob Control; 2014 Mar; 23(2):140-5. PubMed ID: 23485704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "The Big WHY": Philip Morris's failed search for corporate social value.
    McDaniel PA; Malone RE
    Am J Public Health; 2012 Oct; 102(10):1942-50. PubMed ID: 22897536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.